25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 25 of 25 clinical reviews.
A clinical guide to dutasteride (Avodart) use after bariatric surgery, covering altered pharmacokinetics, absorption concerns, dosing strategies, and hair-loss treatment evidence in post-bariatric patients.
Does dutasteride (Avodart) change appetite or food cravings? A physician-reviewed deep dive into the pharmacology, clinical trial data, and patient reports around dutasteride and appetite.
A clinician-level review of dutasteride (Avodart) and autoimmune disease: drug-induced lupus risk, thyroid interactions, immunomodulatory mechanisms, dosing cautions, and how to monitor patients with pre-existing autoimmune conditions.
A comprehensive clinical review of how dutasteride (Avodart) affects bone mineral density, fracture risk, and skeletal health in men with BPH and androgenetic alopecia. Includes trial data, mechanisms, and monitoring guidance.
A physician-level review of dutasteride (Avodart) and cancer risk, covering REDUCE trial data, FDA label updates, high-grade prostate cancer signals, and what this means for patients using dutasteride for BPH or hair loss.
A physician-reviewed deep dive into dutasteride (Avodart) and long-term cardiovascular risk, covering the REDUCE trial, PCPT-era data, MACE signals, lipid effects, and current prescribing guidance for men on 5-alpha-reductase inhibitor therapy.
A physician-reviewed, evidence-based look at dutasteride (Avodart) and cognitive function, covering neurosteroid pathways, clinical trial data, risk stratification, and what patients should discuss with their prescribers.
A physician-reviewed comparison of compounded dutasteride versus branded Avodart covering bioavailability, cost, regulatory status, and clinical evidence for BPH and hair loss.
A GRADE-rated review of dutasteride (Avodart) evidence for BPH and male pattern hair loss, covering landmark RCTs, guideline recommendations, and head-to-head data vs. Finasteride.
What oral dutasteride evidence really shows for male pattern hair loss, what it does not establish about dry skin or sebum, and how its long half-life, sexual effects, fertility, pregnancy-exposure, and PSA warnings change the decision.
A clinical deep-dive into how dutasteride (Avodart) affects liver function, what the trial data shows, when to monitor LFTs, and which patients face the highest risk.
A physician-reviewed deep dive into dutasteride (Avodart) and its effects on mood, depression, anxiety, libido, and cognitive function, with primary-literature citations and clinical guidance.
A physician-reviewed deep dive into how dutasteride (Avodart) is metabolized, how it affects androgen-driven thermogenesis, and what clinicians and patients need to know about energy expenditure changes on long-term therapy.
A physician-reviewed deep dive into dutasteride microdosing protocols for AGA and BPH, covering every published dose-finding trial, pharmacokinetics, sexual side-effect profiles, and how to discuss sub-standard doses with your prescriber.
A clinician-level review of dutasteride (Avodart) and muscle preservation strategies, covering DHT suppression, resistance training protocols, protein targets, and monitoring guidance backed by primary-source evidence.
Why dutasteride (Avodart) stops working for BPH or hair loss, what the evidence says, and the clinical steps to take when you hit a plateau.
Board-reviewed guide on the dutasteride (Avodart) pre-surgery hold window: when to stop, why it matters for PSA, bleeding, and anesthesia, and how to safely restart.
A physician-reviewed, evidence-based breakdown of what happens when you stop dutasteride (Avodart): DHT rebound, hair loss reversal, BPH symptom return, and how to taper safely.
A clinical deep-dive into dutasteride (Avodart) and kidney health: does it protect the kidneys, harm them, or neither? Evidence from primary trials, pharmacokinetic data, and clinical guidelines reviewed by the HealthRX medical team.
What happens when you stop dutasteride during illness, when it's safe to restart, and exactly how to resume therapy after acute illness. Physician-reviewed guidance with primary-literature citations.
A clinician-reviewed guide to dutasteride (Avodart) seasonal use considerations, covering how shedding cycles, temperature, storage, and monitoring schedules interact with 5-alpha reductase inhibitor therapy.
A physician-reviewed, evidence-based look at how dutasteride (Avodart) affects sexual function, including libido, erectile function, and ejaculation, with data from major trials and practical clinical context.
A clinician-level review of how dutasteride (Avodart) affects sleep architecture, including neurosteroid suppression, REM disruption, and clinical management strategies backed by primary literature.
Board-reviewed clinical guide to dutasteride (Avodart) travel protocols, timezone-shift dosing, storage rules, and what to do when doses are missed mid-journey.
A clinician-reviewed, week-by-week guide to the first 30 days on dutasteride (Avodart) for BPH and hair loss. Covers DHT suppression timelines, shedding phases, side effects, and what your lab work should show.